GLOBAL SEPSIS ALLIANCE
Our Mission Statement: Provide global leadership to reduce the worldwide burden of sepsis
Objects
TO RELIEVE SICKNESS AND PROMOTE AND PROTECT THE PHYSICAL AND MENTAL HEALTH OF PERSONS SUFFERING FROM SEPSIS BY:(A) THE PROVISION OF FINANCIAL ASSISTANCE, SUPPORT, EDUCATION, RESEARCH AND PRACTICAL ADVICE;(B) INCREASING AWARENESS AND UNDERSTANDING OF SEPSIS AND THE AND ITS TREATMENT AMONGST HEALTH PROFESSIONALS, CORPORATIONS, GOVERNMENTAL AND NON-GOVERNMENTAL ORGANISATIONS AND THE PUBLIC.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net income of £39,614 for the year ended 31 December 2025, resulting in unrestricted funds increasing to £186,162. The charity has three current employees and no property or significant investments, with total assets less current liabilities standing at £186,162. The trustees acknowledge the need for more comprehensive risk assessments in the future as the organization continues its formative years.
What the accounts disclose
“Insights in Healthcare Ltd provided secretariat services to Global Sepsis Alliance during the year totalling £3,325 (PY - £3,600). Mr. Philip Taylor is common director in both company.” — page 19
Policies the charity declares
- Paying staff
Trustees
- PROFESSOR KONRAD REINHARTchair
- PHILIP TAYLOR
- RON DANIELS
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £365k | £326k |
| 31/12/2024 | £119k | £449k |
| 31/12/2023 | £322k | £477k |
| 31/12/2022 | £254k | £373k |
| 31/12/2021 | £343k | £209k |
Common questions
Is GLOBAL SEPSIS ALLIANCE financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net income of £39,614 for the year ended 31 December 2025, resulting in unrestricted funds increasing to £186,162. The charity has three current employees and no property or significant investments, with total assets less current liabilities standing at £186,162. The trustees acknowledge the need for more comprehensive risk assessments in the future as the organization continues its formative years. Its FY2025 accounts were independently examined.